AHA Statement on Examining Oversight Reports on the 340B Drug Pricing Program

AHA Statement before the Senate Committee on Health, Education, Labor and Pensions: Examining Oversight Reports on the 340B Drug Pricing Program

Related Resources

Webinar Recordings
Member
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took…
Letter/Comment
Public
Dear Secretary Azar: On behalf of our nearly 2,000 340B member hospitals, the American Hospital Association (AHA) urges the Department of Health and Human…
Letter/Comment
Public
The AHA submitted its comments to the Office of Management and Budget regarding the Centers for Medicare & Medicaid Services (CMS) plans to collect pricing…
Guides/Reports
Member
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec lacus justo, scelerisque ut orci vitae, venenatis dignissim sapien. In vitae enim quis purus…
Letter/Comment
Letter/Comment
Member Non-Fed
mark { background-color: yellow; color: black; } [Put on Hospital Letterhead] [DATE] Seema Verma Administrator Centers for Medicare & Medicaid…